Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients

Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. Objective To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP i...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 33; no. 12; pp. 2327 - 2333
Main Authors Yang, A., Xuan, R.R., Melbourne, W., Hashimoto, T., Uzun, S., Daneshpazhooh, M., Yamagami, J., Di Zenzo, G., Mascaro, J.M., Mahmoudi, H., Patsatsi, A., Drenovska, K., Vassileva, S., Murrell, D.F.
Format Journal Article
LanguageEnglish
Published England 01.12.2019
Subjects
Online AccessGet full text
ISSN0926-9959
1468-3083
1468-3083
DOI10.1111/jdv.15817

Cover

Abstract Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. Objective To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV). Methods Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1–5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de‐identified. Fleiss Kappa was used to estimate the IRR. Results Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt‐Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter‐rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001). Conclusion The BIOCHIP mosaic‐based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.
AbstractList The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. To validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV). Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR. Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001). The BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.
The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.BACKGROUNDThe BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus.To validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).OBJECTIVETo validate the accuracy and inter-rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV).Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR.METHODSSera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1-5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de-identified. Fleiss Kappa was used to estimate the IRR.Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).RESULTSFleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt-Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter-rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001).The BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.CONCLUSIONThe BIOCHIP mosaic-based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.
Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological diagnosis of bullous pemphigoid (BP) and pemphigus. Objective To validate the accuracy and inter‐rater reliability (IRR) of the BIOCHIP in the diagnosis of BP, pemphigus foliaceus (PF) and pemphigus vulgaris (PV). Methods Sera from patients with BP (n = 38), PF (n = 8), PV (n = 23), control patients (n = 64) and healthy control volunteers (n = 39) were tested. Sera were collected and analysed during the course of the disease at 1–5 different time points. The BIOCHIP was performed for all patients, digital images were captured of each incubated field, and the images were shared with 10 dermatologists experienced in reading IF from around the world to report. There were 312 BIOCHIP slides consisting of 1872 photos in total. All patients were de‐identified. Fleiss Kappa was used to estimate the IRR. Results Fleiss Kappa was computed for each category (Oesophagus, Oesophagus immunofluorescence pattern, Salt‐Split Skin (SSS), SSS immunofluorescence location, BP180, BP230, Dsg 1 and Ds3). The inter‐rater agreement between the 10 raters varied between fair and moderate for all categories. Those that demonstrated fair concordance included monkey oesophagus (k = 0.257, P < 0.0001), oesophagus pattern (k = 0.357, P < 0.0001), Dsg1 (k = 0.390, P < 0.0001) and BP230 (k = 0.281, P < 0.0001). Moderate agreement was demonstrated for SSS (k = 0.416, P < 0.0001), SSS immunofluorescence location (k = 0.505, P < 0.0001), Dsg3 (k = 0.437, P < 0.0001) and BP180 (k = 0.559, P < 0.0001). Conclusion The BIOCHIP mosaic‐based immunofluorescence test is a simple, time and effort saving test that can aid in the diagnosis and screening of BP, PV and PF. However, the level of agreement was relatively low. The authors found the most common causes to be variable levels of training, indicating the presence of a learning curve in the interpretation of the results and ambiguous staining patterns leading to incongruent results.
Author Hashimoto, T.
Yamagami, J.
Di Zenzo, G.
Uzun, S.
Vassileva, S.
Melbourne, W.
Daneshpazhooh, M.
Mascaro, J.M.
Patsatsi, A.
Xuan, R.R.
Mahmoudi, H.
Drenovska, K.
Yang, A.
Murrell, D.F.
Author_xml – sequence: 1
  givenname: A.
  orcidid: 0000-0002-9184-5484
  surname: Yang
  fullname: Yang, A.
  organization: St George Hospital
– sequence: 2
  givenname: R.R.
  orcidid: 0000-0001-6893-4422
  surname: Xuan
  fullname: Xuan, R.R.
  organization: University of New South Wales
– sequence: 3
  givenname: W.
  surname: Melbourne
  fullname: Melbourne, W.
  organization: St George Hospital
– sequence: 4
  givenname: T.
  surname: Hashimoto
  fullname: Hashimoto, T.
  organization: Osaka City University Graduate School of Medicine
– sequence: 5
  givenname: S.
  surname: Uzun
  fullname: Uzun, S.
  organization: Akdeniz University School of Medicine
– sequence: 6
  givenname: M.
  orcidid: 0000-0003-1020-8895
  surname: Daneshpazhooh
  fullname: Daneshpazhooh, M.
  organization: Tehran University of Medical Sciences
– sequence: 7
  givenname: J.
  surname: Yamagami
  fullname: Yamagami, J.
  organization: Keio University School of Medicine
– sequence: 8
  givenname: G.
  surname: Di Zenzo
  fullname: Di Zenzo, G.
  organization: IDI‐IRCCS
– sequence: 9
  givenname: J.M.
  surname: Mascaro
  fullname: Mascaro, J.M.
  organization: Hospital Clinic and Barcelona University Medical School
– sequence: 10
  givenname: H.
  orcidid: 0000-0002-1890-1005
  surname: Mahmoudi
  fullname: Mahmoudi, H.
  organization: Tehran University of Medical Sciences
– sequence: 11
  givenname: A.
  orcidid: 0000-0001-9616-2001
  surname: Patsatsi
  fullname: Patsatsi, A.
  organization: Aristotle University School of Medicine
– sequence: 12
  givenname: K.
  surname: Drenovska
  fullname: Drenovska, K.
  organization: Sofia University of Medicine
– sequence: 13
  givenname: S.
  surname: Vassileva
  fullname: Vassileva, S.
  organization: Sofia University of Medicine
– sequence: 14
  givenname: D.F.
  surname: Murrell
  fullname: Murrell, D.F.
  email: d.murrell@unsw.edu.au
  organization: St George Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31325388$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9u1DAQxi3Uim4LB14A-QiHtHacOPERlj_dqlI5AFfLsSetK8debAe0Nw48AM_Ik-Dt7l4q8GVkze_7NDPfKTrywQNCLyg5p-Vd3Jvv57TtafcELWjD-4qRnh2hBRE1r4RoxQk6TemeEEIL9hSdMMrqlvX9Av1a-Qzxz8_fUZWKIzirButs3uAw4nwH-O3qZnm5-oStNzaCzthO0-zD6OYQIWnwGrCBOKkcXLjd4CkkZXXB8TA7F-aE1zCt7-xtsAYrbw7fbUNlCz6nZ-h4VC7B8309Q18-vP-8vKyubz6ulm-uK80E7SpQ9TByRfRATMug6bQyMKiRd2OjRMNYQ1rWCNULSgzVSnHCW1NO0RFt-rZjZ-jVzncdw7cZUpaTLRs4pzyUQWVdcyp4X_Mt-nKPzsMERq6jnVTcyMPlCnCxA3QMKUUYpba57BN8jso6SYncZiNLNvIhm6J4_UhxMP0Xu3f_YR1s_g_Kq3dfd4q_ZDChfg
CitedBy_id crossref_primary_10_1016_j_jaad_2020_11_076
crossref_primary_10_23736_S0392_0488_19_06517_9
crossref_primary_10_3389_fimmu_2023_1111172
crossref_primary_10_3390_brainsci13091286
crossref_primary_10_1007_s15011_021_4839_0
crossref_primary_10_3389_fimmu_2024_1426834
crossref_primary_10_1080_1744666X_2021_1945925
crossref_primary_10_1111_jdv_17087
Cites_doi 10.1046/j.0022-202X.2003.22126.x
10.1037/0021-9010.93.5.959
10.1016/j.ijwd.2015.01.002
10.1007/s00403-016-1632-0
10.1016/0022-2496(66)90002-2
10.1046/j.1523-1747.1999.00632.x
10.1016/S0190-9622(99)70183-0
10.1111/j.1365-2230.2010.03845.x
10.1111/jdv.15770
10.1186/1750-1172-7-49
10.1037/h0031619
10.1111/j.1346-8138.2011.01382.x
10.1111/1523-1747.ep12616580
10.1016/S0140-6736(05)66829-8
10.1172/JCI113803
10.1159/000339776
10.1016/j.acthis.2013.12.012
10.1046/j.1365-2133.1999.02752.x
10.1037/h0031643
10.1111/j.1365-2133.2004.06082.x
10.2307/2529310
10.1016/j.autrev.2014.01.011
10.1016/j.det.2011.03.012
10.1016/S0923-1811(02)00109-3
ContentType Journal Article
Copyright 2019 European Academy of Dermatology and Venereology
2019 European Academy of Dermatology and Venereology.
Copyright_xml – notice: 2019 European Academy of Dermatology and Venereology
– notice: 2019 European Academy of Dermatology and Venereology.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jdv.15817
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3083
EndPage 2333
ExternalDocumentID 31325388
10_1111_jdv_15817
JDV15817
Genre article
Journal Article
GroupedDBID ---
--K
.3N
.GA
.Y3
05W
0R~
10A
1B1
1OB
1OC
1~5
29L
31~
33P
36B
3SF
4.4
4G.
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AALRI
AAMNL
AANHP
AANLZ
AAONW
AAQFI
AAQXK
AASGY
AAXRX
AAXUO
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABJNI
ABQWH
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADZMN
AE3
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFTJW
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CO8
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
ESX
EX3
F00
F01
F04
F5P
FDB
FEDTE
FGOYB
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
NQ-
O66
O9-
OIG
OVD
OZT
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
R2-
RIG
RIWAO
RJQFR
ROL
RPZ
RX1
SAMSI
SEW
SUPJJ
TEORI
UB1
UHS
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAYXX
ACVFH
ADCNI
AEUPX
AEYWJ
AFPUW
AGHNM
AGQPQ
AGYGG
AIGII
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3917-ea2bf6a0cb0d53e47cadebaf67f4a9433405349a8910d1caa6065d08370cd8573
IEDL.DBID DR2
ISSN 0926-9959
1468-3083
IngestDate Thu Jul 10 23:44:32 EDT 2025
Wed Feb 19 02:30:47 EST 2025
Thu Apr 24 23:03:37 EDT 2025
Tue Jul 01 04:12:01 EDT 2025
Wed Jan 22 16:36:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2019 European Academy of Dermatology and Venereology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3917-ea2bf6a0cb0d53e47cadebaf67f4a9433405349a8910d1caa6065d08370cd8573
Notes None.
Conflict of interest
Funding source
None declared.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9184-5484
0000-0002-1890-1005
0000-0001-9616-2001
0000-0003-1020-8895
0000-0001-6893-4422
PMID 31325388
PQID 2261968267
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_2261968267
pubmed_primary_31325388
crossref_citationtrail_10_1111_jdv_15817
crossref_primary_10_1111_jdv_15817
wiley_primary_10_1111_jdv_15817_JDV15817
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2019
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: December 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the European Academy of Dermatology and Venereology
PublicationTitleAlternate J Eur Acad Dermatol Venereol
PublicationYear 2019
References 2015; 1
2004; 122
1966; 3
2014; 116
2002; 30
2016; 308
2017; 25
1999; 140
2012; 39
1999; 40
2011; 36
2012; 225
1992; 99
1995; 4
2008; 93
2015; 173
1971; 76
1977; 159–74
2005; 366
2004; 151
2019
2014; 13
1999; 113
1977; 33
2012; 7
1988; 82
2011; 29
2012; 21
e_1_2_6_10_1
e_1_2_6_30_1
Landis JR (e_1_2_6_18_1) 1977; 159
Van Beek N (e_1_2_6_23_1) 2012; 21
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_15_1
e_1_2_6_20_1
Ozkesici B (e_1_2_6_24_1) 2017; 25
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
Hashimoto T (e_1_2_6_16_1) 1995; 4
e_1_2_6_25_1
e_1_2_6_3_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
Chiang YZ (e_1_2_6_21_1) 2015; 173
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 25
  start-page: 202
  year: 2017
  end-page: 209
  article-title: The Value of the BIOCHIP mosaic‐based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid In turkish patients
  publication-title: Acta Dermatovenerol Croat
– volume: 1
  start-page: 4
  year: 2015
  end-page: 12
  article-title: Autoimmune blistering diseases in females: a review
  publication-title: Int J Womens Dermatol
– volume: 3
  start-page: 1
  year: 1966
  end-page: 18
  article-title: The axioms and principal results of classical test theory
  publication-title: J Math Psychol
– volume: 113
  start-page: 22
  year: 1999
  end-page: 25
  article-title: Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice
  publication-title: J Invest Dermatol
– volume: 39
  start-page: 141
  year: 2012
  end-page: 144
  article-title: Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires
  publication-title: J Dermatol
– volume: 36
  start-page: 12
  year: 2011
  end-page: 18
  article-title: Clinical and immunopathological evaluation of epidermolysis bullosa acquisita
  publication-title: Clin Exp Dermatol
– volume: 40
  start-page: 167
  issue: 2 Pt 1
  year: 1999
  end-page: 170
  article-title: The clinical phenotype of pemphigus is defined by the anti‐desmoglein autoantibody profile
  publication-title: J Am Acad Dermatol
– volume: 366
  start-page: 61
  year: 2005
  end-page: 73
  article-title: Pemphigus
  publication-title: Lancet
– volume: 159–74
  year: 1977
  article-title: The measurement of observer agreement for categorical data
  publication-title: Biometrics
– volume: 29
  start-page: 405
  year: 2011
  end-page: 412
  article-title: Diagnosis and clinical features of pemphigus foliaceus
  publication-title: Dermatol Clin
– volume: 173
  start-page: 7
  year: 2015
  end-page: 8
  article-title: Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases
  publication-title: Br J Dermatol
– volume: 33
  start-page: 159
  year: 1977
  end-page: 174
  article-title: The measurement of observer agreement for categorical data
  publication-title: Biometrics
– year: 2019
  article-title: Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceous
  publication-title: J Eur Acad Dermatol Venereol
– volume: 99
  start-page: 243
  year: 1992
  end-page: 250
  article-title: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180
  publication-title: J Invest Dermatol
– volume: 76
  start-page: 365
  year: 1971
  end-page: 377
  article-title: Measures of response agreement for qualitative data: some generalizations and alternatives
  publication-title: Psychol Bull
– volume: 93
  start-page: 959
  year: 2008
  end-page: 981
  article-title: Ill‐structured measurement designs in organizational research: implications for estimating interrater reliability
  publication-title: J Appl Psychol
– volume: 4
  start-page: 63
  year: 1995
  end-page: 69
  article-title: Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1
  publication-title: Epithelial Cell Biol
– volume: 7
  start-page: 49
  year: 2012
  article-title: Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic‐based indirect immunofluorescence technique with the conventional multi‐step single test strategy
  publication-title: Orphanet J Rare Dis
– volume: 13
  start-page: 477
  year: 2014
  end-page: 481
  article-title: Diagnosis and classification of pemphigus and bullous pemphigoid
  publication-title: Autoimmun Rev
– volume: 82
  start-page: 1864
  year: 1988
  end-page: 1870
  article-title: Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies
  publication-title: J Clin Invest
– volume: 225
  start-page: 37
  year: 2012
  end-page: 44
  article-title: Anti‐skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases
  publication-title: Dermatology
– volume: 30
  start-page: 224
  year: 2002
  end-page: 232
  article-title: BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid
  publication-title: J Dermatol Sci
– volume: 140
  start-page: 351
  year: 1999
  end-page: 357
  article-title: Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus
  publication-title: Br J Dermatol
– volume: 308
  start-page: 273
  year: 2016
  end-page: 276
  article-title: The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita
  publication-title: Arch Dermatol Res
– volume: 21
  start-page: e34
  year: 2012
  article-title: Prospective comparison of a specially composed biochip mosaic with the conventional multistep procedure in the serological diagnosis of autoimmune bullous diseases
  publication-title: Exp Dermatol
– volume: 122
  start-page: 103
  year: 2004
  end-page: 110
  article-title: Characterization of the anti‐BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients
  publication-title: J Invest Dermatol
– volume: 116
  start-page: 713
  year: 2014
  end-page: 716
  article-title: The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris
  publication-title: Acta Histochem
– volume: 151
  start-page: 126
  year: 2004
  end-page: 131
  article-title: Evaluation of a BP180‐NC16a enzyme‐linked immunosorbent assay in the initial diagnosis of bullous pemphigoid
  publication-title: Br J Dermatol
– volume: 76
  start-page: 378
  year: 1971
  article-title: Measuring nominal scale agreement among many raters
  publication-title: Psychol Bull
– ident: e_1_2_6_8_1
  doi: 10.1046/j.0022-202X.2003.22126.x
– ident: e_1_2_6_26_1
  doi: 10.1037/0021-9010.93.5.959
– ident: e_1_2_6_3_1
  doi: 10.1016/j.ijwd.2015.01.002
– volume: 4
  start-page: 63
  year: 1995
  ident: e_1_2_6_16_1
  article-title: Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1
  publication-title: Epithelial Cell Biol
– ident: e_1_2_6_30_1
  doi: 10.1007/s00403-016-1632-0
– ident: e_1_2_6_25_1
  doi: 10.1016/0022-2496(66)90002-2
– ident: e_1_2_6_14_1
  doi: 10.1046/j.1523-1747.1999.00632.x
– volume: 173
  start-page: 7
  year: 2015
  ident: e_1_2_6_21_1
  article-title: Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases
  publication-title: Br J Dermatol
– ident: e_1_2_6_12_1
  doi: 10.1016/S0190-9622(99)70183-0
– ident: e_1_2_6_29_1
  doi: 10.1111/j.1365-2230.2010.03845.x
– ident: e_1_2_6_4_1
  doi: 10.1111/jdv.15770
– ident: e_1_2_6_22_1
  doi: 10.1186/1750-1172-7-49
– ident: e_1_2_6_17_1
  doi: 10.1037/h0031619
– volume: 159
  year: 1977
  ident: e_1_2_6_18_1
  article-title: The measurement of observer agreement for categorical data
  publication-title: Biometrics
– ident: e_1_2_6_2_1
  doi: 10.1111/j.1346-8138.2011.01382.x
– ident: e_1_2_6_6_1
  doi: 10.1111/1523-1747.ep12616580
– ident: e_1_2_6_10_1
  doi: 10.1016/S0140-6736(05)66829-8
– ident: e_1_2_6_5_1
  doi: 10.1172/JCI113803
– ident: e_1_2_6_20_1
  doi: 10.1159/000339776
– volume: 21
  start-page: e34
  year: 2012
  ident: e_1_2_6_23_1
  article-title: Prospective comparison of a specially composed biochip mosaic with the conventional multistep procedure in the serological diagnosis of autoimmune bullous diseases
  publication-title: Exp Dermatol
– volume: 25
  start-page: 202
  year: 2017
  ident: e_1_2_6_24_1
  article-title: The Value of the BIOCHIP mosaic‐based indirect immunofluorescence technique in the diagnosis of pemphigus and bullous pemphigoid In turkish patients
  publication-title: Acta Dermatovenerol Croat
– ident: e_1_2_6_19_1
  doi: 10.1016/j.acthis.2013.12.012
– ident: e_1_2_6_11_1
  doi: 10.1046/j.1365-2133.1999.02752.x
– ident: e_1_2_6_27_1
  doi: 10.1037/h0031643
– ident: e_1_2_6_9_1
  doi: 10.1111/j.1365-2133.2004.06082.x
– ident: e_1_2_6_28_1
  doi: 10.2307/2529310
– ident: e_1_2_6_13_1
  doi: 10.1016/j.autrev.2014.01.011
– ident: e_1_2_6_15_1
  doi: 10.1016/j.det.2011.03.012
– ident: e_1_2_6_7_1
  doi: 10.1016/S0923-1811(02)00109-3
SSID ssj0001158
Score 2.3094327
Snippet Background The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the...
The BIOCHIP (Dermatology Mosaic 7; EUROIMMUN, Lubeck, Germany) is a novel multiplex indirect immunofluorescence (IIF) technique used in the serological...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2327
SubjectTerms Case-Control Studies
Fluorescent Antibody Technique - methods
Humans
Observer Variation
Pemphigoid, Bullous - diagnosis
Title Inter‐rater reliability of the BIOCHIP indirect immunofluorescence dermatology mosaic in bullous pemphigoid and pemphigus patients
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjdv.15817
https://www.ncbi.nlm.nih.gov/pubmed/31325388
https://www.proquest.com/docview/2261968267
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8UwEA7iQby4L8-NKB689NG9KZ5ceQouiIoHoWSrPNRW3gbPkwd_gL_RX-JM2j53EG8tnaZpMpN8k8x8IWQ9EB56DZ4FWFVbvnRji_mYjaaE78Tac7WN2chHx2Hjwj-8Cq6GyGaVC1PwQwwW3NAyzHiNBs5F-6ORq17dCZiDmeSOFyJv_u7ZO3UUIB0zCsduaCGnVskqZKJ4qjc_z0XfAOZnvGomnP1xcl1VtYgzua13O6IuH7-wOP7zXybIWAlE6VahOZNkSGdTZOSo3GqfJs9mrfD16QW5JFq0BV8oKL37NE8pwEa6fXCy0zg4pbjrjeMmbWKuSZ7edfOWIYmSmioc-M0RuX16n7d5U4I4FeD35t02fdCgS82bvKkoz1R1iw8Kttf2DLnY3zvfaVjlkQ2W9MDxszR3RRpyWwpbBZ72IwzyFzwNo9TnoBKgGIHnx5wBSlGO5Bz8p0DZyMAjFQsib5YMZ3mm5wmNI64ZFyGTCpxAETMR2dplAYt9CaWJGtmoOi-RJZ85Hqtxlwz8GtVLTKvWyNpA9KEg8fhJaLXSgARMDPdNeKahMRIXvcwQ_DCQmStUY1AMMl_CnMGgNqaDfy8_Ody9NBcLfxddJKMA0OIifGaJDHdaXb0MIKgjVoy2vwEonAVQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkEov0Actj5a6FYdessrm6Ui9UArapSxFCCouKPIr1YolQftAglMP_AB-I7-kM06yvIqEuCXKxHHssf2NZ-YzwGoofbIafAexqnEC5SUODygbTcugmRjfMy5lI3d2otZBsHUYHk7AtzoXpuSHGG-40ciw8zUNcNqQvj3K9VmjGfJmPAnT1j9HkGjvhjwKsY6dhxMvcohVq-IVsnE89at3V6MHEPMuYrVLzuYcHNWVLSNNjhujoWyoi3s8js_9m1cwW2FRtlYqz2uYMPkbeNGpvO1v4dJuF17_vSI6iT7r4ydKVu9zVmQMkSP73v613mrvMnJ809TJupRuUmS9UdG3PFHKME1zvz0l95ydFAPRVSjOJNarGA3YqUF16v4pupqJXNe39KAkfB3Mw8Hmxv56y6lObXCUj7afY4Qns0i4Sro69E0QU5y_FFkUZ4FArUDdCP0gERyBim4qIdCECrVLJDxK8zD238FUXuRmAVgSC8OFjLjSaAfKhMvYNR4PeRIoLE0uwte691JVUZrTyRq9dGza6LPUtuoifBmLnpY8Hv8T-lyrQIqjjFwnIjfYGKlHhmaEphjKvC91Y1wMkV_issGxNraHHy8_3frx214sPV30E8y09jvb6XZ75-cyvES8lpTRNB9gatgfmY-IiYZyxar-P2zrCW4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlVAv0CfPUlP10EtW2cRJHPVEgdUuryIEFYdKkV9BKyBZ7QOJnnroD-hv7C_pjJMspQ-p4pYoE8exxzPf2OPPAG8jFVLUEHqIVa3HdZB6gtNuNKN4O7VhYH3ajXx4FHfP-N55dD4D75u9MBU_xHTCjUaGs9c0wAcm_3WQm5tWOxLtZBYe8RjdJCGikzvuKIQ6zgynQewRqVZNK-TSeJpX7zujPxDmfcDqPE5nET43da0STS5bk7Fq6S-_0Tg-8GeewEKNRNlWpTpPYcYWz2D-sF5rfw7f3GThj6_fiUxiyIb4hYrT-5aVOUPcyD70Pm53e8eMlr3JcLI-bTYp86tJOXQsUdoyQ5bfnZF7y67LkexrFGcKA99yMmIDi8rUvyj7hsnCNLf0oKJ7Hb2As87u6XbXq89s8HSIkZ9nZaDyWPpa-SYKLU8oy1_JPE5yLlEnUDOikKdSIEwxbS0lBlCR8YmCRxsRJeFLmCvKwi4DSxNphVSx0AajQJUKlfg2EJFIucbS1Aq8azov0zWhOZ2rcZVNAxtzk7lWXYE3U9FBxeLxN6HNRgMyHGO0cCILi42RBRRmxhiIocxSpRrTYoj6Ep2GwNq4Dv53-dnezid3sfr_oq9h_ninkx30jvbX4DGCtbRKpVmHufFwYl8hIBqrDaf4PwFXnggd
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inter-rater+reliability+of+the+BIOCHIP+indirect+immunofluorescence+dermatology+mosaic+in+bullous+pemphigoid+and+pemphigus+patients&rft.jtitle=Journal+of+the+European+Academy+of+Dermatology+and+Venereology&rft.au=Yang%2C+A&rft.au=Xuan%2C+R+R&rft.au=Melbourne%2C+W&rft.au=Hashimoto%2C+T&rft.date=2019-12-01&rft.issn=1468-3083&rft.eissn=1468-3083&rft.volume=33&rft.issue=12&rft.spage=2327&rft_id=info:doi/10.1111%2Fjdv.15817&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0926-9959&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0926-9959&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0926-9959&client=summon